DNA treatment helps stop melanoma Genentech's Vemurafenib Meets Primary Endpoints In Phase 3 Study - Quick Facts New Drugs in treatment of metastatic melanoma Vemurafenib and Ipilimumab — buying time for Melanoma sufferers